Table 1

Demographic data pH data and endoscopic results for patients before therapy with esomeprazole at baseline assessment
Screening pH negative symptom relief 40 mg q.d. symptom relief 40 mg b.i.d. persistence
n = 31 n = 9 n = 19 n = 2 n = 1
Gender (male/female) 12/19 0/9 9/10 2/0 1/0
Age (mean±SD) 52.4±17.1 years 47.5±3.5 years 52.5± 2.8 years 23.7± 5.1 years 66 years
Endoscopy
NERD 7 (no erosions) 7
ERD Los Angeles A 2 4 1 1
ERD Los Angeles B 5 1
ERD Los Angeles C 1
Barrett’s Esophagus 2
DeMeester score ±SD _ 5.5 ± 1.8 26.9 ± 3.9 20.9 ± 15.7 30.3
‐ DeMeester [day 1] _ 5.9 ± 2.9 28.2 ± 4.8 21.6 ± 19.8 23.2
‐ DeMeester [day 2] _ 4.9 ± 2.4 25.6 ± 3.9 10.7 ± 3.5 34.8

Kandulski et al.

Kandulski et al. BMC Gastroenterology 2013 13:12   doi:10.1186/1471-230X-13-12

Open Data